ALGS vs ICE · rev $3.6M vs P/E 37, rev $12.64B
Aligos Therapeutics Inc (ALGS) versus Intercontinental Exchange Inc (ICE) — a side-by-side from cached financials, not a winner call.
Aligos Therapeutics Inc (ALGS) is a biotechnology company listed on US.
Intercontinental Exchange Inc (ICE) is a financial data & stock exchanges company listed on US.
Latest reported ALGS revenue for 2024-12-31 was $3.6M. Net income was -$131.2M. Revenue was down 41.7% from 2023-12-31 to 2024-12-31. ALGS currently screens at market cap $44.1M.
Latest reported ICE revenue for 2025-12-31 was $12.64B. Net income was $3.31B. Revenue was up 7.5% from 2024-12-31 to 2025-12-31. ICE currently screens at market cap $103.55B and trailing P/E 37.3.
ALGS currently screens at market cap $44.1M. ICE currently screens at market cap $103.55B and trailing P/E 37.3.
Not investment advice. Open the ALGS and ICE stock pages for the full models.
Not investment advice.